Supplementary Fig. S3 from Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer

MLA

Toshiyoshi Fujiwara, et al. Supplementary Fig. S3 from Preclinical Evaluation of Synergistic Effect of Telomerase-Specific Oncolytic Virotherapy and Gemcitabine for Human Lung Cancer. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1535-7163.22485083.

APA

Toshiyoshi Fujiwara, Yasuo Urata, Hideki Onimatsu, Yuuri Hashimoto, Yuichi Watanabe, Shinji Kuroda, Masaaki Ouchi, Toru Kojima, & Dong Liu. (2023). Supplementary Fig. S3 from Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer. https://doi.org/10.1158/1535-7163.22485083

Chicago

Toshiyoshi Fujiwara, Yasuo Urata, Hideki Onimatsu, Yuuri Hashimoto, Yuichi Watanabe, Shinji Kuroda, Masaaki Ouchi, Toru Kojima, and Dong Liu. 2023. “Supplementary Fig. S3 from Preclinical Evaluation of Synergistic Effect of Telomerase-Specific Oncolytic Virotherapy and Gemcitabine for Human Lung Cancer,” March. doi:10.1158/1535-7163.22485083.